AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Net Margin Growth (3y) (2024 - 2025)

Analysis

AtaiBeckley (ATAI) Net Margin Growth (3y) (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -374.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -44.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 6,620.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -13,815.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7,793.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 9,934.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -5,319.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 31,387.00
10 AtaiBeckley 1.61 Bn 1.61 Bn - 13.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 13.30 Mn
Jun 30, 2025 1.77 Mn
Dec 31, 2024 -29.92 Mn
Sep 30, 2024 -5.40 Mn